JP2022551656A5 - - Google Patents

Info

Publication number
JP2022551656A5
JP2022551656A5 JP2022521574A JP2022521574A JP2022551656A5 JP 2022551656 A5 JP2022551656 A5 JP 2022551656A5 JP 2022521574 A JP2022521574 A JP 2022521574A JP 2022521574 A JP2022521574 A JP 2022521574A JP 2022551656 A5 JP2022551656 A5 JP 2022551656A5
Authority
JP
Japan
Prior art keywords
subject
diabetes
marker
acid
level
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022521574A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022551656A (ja
JP7607951B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/055020 external-priority patent/WO2021072222A1/en
Publication of JP2022551656A publication Critical patent/JP2022551656A/ja
Publication of JP2022551656A5 publication Critical patent/JP2022551656A5/ja
Application granted granted Critical
Publication of JP7607951B2 publication Critical patent/JP7607951B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022521574A 2019-10-11 2020-10-09 妊娠性糖尿病に関する代謝プロファイルスクリーニング Active JP7607951B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962914294P 2019-10-11 2019-10-11
US62/914,294 2019-10-11
PCT/US2020/055020 WO2021072222A1 (en) 2019-10-11 2020-10-09 Metabolic profile screening for gestational diabetes

Publications (3)

Publication Number Publication Date
JP2022551656A JP2022551656A (ja) 2022-12-12
JP2022551656A5 true JP2022551656A5 (https=) 2023-10-17
JP7607951B2 JP7607951B2 (ja) 2025-01-06

Family

ID=75436783

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022521574A Active JP7607951B2 (ja) 2019-10-11 2020-10-09 妊娠性糖尿病に関する代謝プロファイルスクリーニング

Country Status (8)

Country Link
US (1) US20240085432A1 (https=)
EP (1) EP4022299A4 (https=)
JP (1) JP7607951B2 (https=)
KR (1) KR20220079582A (https=)
CN (1) CN114761794A (https=)
AU (1) AU2020361608A1 (https=)
CA (1) CA3157057A1 (https=)
WO (1) WO2021072222A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114167066B (zh) * 2022-01-24 2022-06-21 杭州凯莱谱精准医疗检测技术有限公司 生物标志物在制备妊娠糖尿病诊断试剂中的用途
CN117187381B (zh) * 2023-11-03 2024-02-13 南京医科大学 一种用于妊娠期糖尿病早期辅助诊断的甲基化区域标志物组合及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005058142A2 (en) 2003-12-16 2005-06-30 Emory University Diabetes diagnostic
CA2690541A1 (en) * 2007-07-17 2009-01-29 Metabolon, Inc. Biomarkers for pre-diabetes, cardiovascular diseases, and other metabolic-syndrome related disorders and methods using the same
WO2012058298A1 (en) * 2010-10-26 2012-05-03 Mayo Foundation For Medical Education And Research Biomarkers of reduced insulin action
EP3094968B1 (en) * 2014-01-15 2020-12-09 The Regents of The University of California Metabolic screening for gestational diabetes
JP2019027885A (ja) 2017-07-28 2019-02-21 国立大学法人千葉大学 妊娠糖尿病の発症リスクの診断用バイオマーカー
US20190310269A1 (en) * 2018-04-04 2019-10-10 Human Longevity, Inc. Systems and methods for measuring obesity using metabolome analysis

Similar Documents

Publication Publication Date Title
JP2020527946A5 (https=)
CN110231452B (zh) 基于等温吸附曲线预测土壤粘粒含量或盐分含量的方法
CN106434924B (zh) 一种利用qPCR精确定量不同GC含量的二代测序文库的方法及试剂盒
CN109632891B (zh) 一种利用阵列气体传感器监测气体种类以及浓度的方法
JP6907388B2 (ja) 核酸増幅反応を分析するための分析方法およびシステム
JP2022551656A5 (https=)
IL315032A (en) Analysis of cell-free dna in urine and other samples
JP2007033132A5 (https=)
Mak et al. Development and validation of a liquid chromatography–tandem mass spectrometry (LC–MS/MS) assay to quantify serum voriconazole
JP2012521551A5 (https=)
CN118038981A (zh) 一种基于qPCR扩增曲线曲率变化提取Cq值的方法及测量仪
Ottaviani et al. C reactive protein and alpha1-antitrypsin: relationship between levels and gene variants
JP5522365B2 (ja) 代謝物の異常度の取得方法、代謝異常の判定方法、及びそのプログラム、並びに、代謝物の異常度の取得装置、及び代謝異常の判定に基づく診断プログラム
JP2024507652A5 (https=)
Kavsak et al. Comparison of two biomarker only algorithms for early risk stratification in patients with suspected acute coronary syndrome
CN108287200B (zh) 质谱参照数据库的建立方法及基于其的物质分析方法
CN111896497A (zh) 一种基于预测值的光谱数据修正方法
Hegde et al. Prevalence of abnormal left ventricular global longitudinal strain by speckle tracking echocardiography and its prognostic value in patients with COVID-19
CN118758233B (zh) 高层建筑中的混凝土裂缝检测方法
JP2014235023A (ja) 液体クロマトグラフィーを用いたヘモグロビンfの定量方法
US20150347674A1 (en) System and method for analyzing biological sample
CN115201195B (zh) 线材偏析程度测定方法
CN101988121A (zh) 小麦谷粒中禾谷镰孢菌侵染量的定量检测技术
CN115083617B (zh) 流行性疾病检测装置及方法
Berger et al. Detection and quantitation of HBV DNA in miniaturized samples: multi centre study to evaluate the performance of the COBAS® AmpliPrep/COBAS® TaqMan® hepatitis B virus (HBV) test v2. 0 by the use of plasma or serum specimens